BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32223036)

  • 21. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
    Porwit A; Béné MC
    Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
    Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
    Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in patients with mixed phenotype acute leukemia in Morocco.
    Bachir F; Zerrouk J; Howard SC; Graoui O; Lahjouji A; Hessissen L; Bennani S; Quessar A; El Aouad R
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e392-7. PubMed ID: 23619119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
    Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
    Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
    Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing and treating mixed phenotype acute leukemia: a multicenter 10-year experience in México.
    Deffis-Court M; Alvarado-Ibarra M; Ruiz-Argüelles GJ; Rosas-López A; Barrera-Lumbreras G; Aguayo-González A; López-Karpovitch X; López-Hernández M; Velázquez-Sánchez de Cima S; Zamora-Ortiz G; Crespo-Solís E
    Ann Hematol; 2014 Apr; 93(4):595-601. PubMed ID: 24146232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical Effect and Safety of CCLG-ALL 2008 (high risk group) Protocol in the Treatment of Childhood Mixed Phenotype Acute Leukemia].
    Zheng YZ; LE SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Li M; Cai CX; Yang JH; Chen YQ; Gao QL; Chen YY; Pan LL; Li J; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):49-55. PubMed ID: 33554796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
    Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.
    Charles NJ; Boyer DF
    Arch Pathol Lab Med; 2017 Nov; 141(11):1462-1468. PubMed ID: 29072953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed phenotype acute leukemia.
    Ye Z; Wang S
    Chin Med J (Engl); 2014; 127(16):2999-3003. PubMed ID: 25131241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia With
    Lin N; Yan X; Cai D; Wang L
    Front Oncol; 2021; 11():709036. PubMed ID: 34395283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of EGIL1998 and WHO2008 criteria for the diagnosis of mixed phenotype acute leukemia].
    Ye L; Lin D; Mi YC; Zhang J; Wang Y; Wang HJ; Wei H; Liu BC; Zhou CL; Li W; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):286-90. PubMed ID: 22781719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
    Duong VH; Begna KH; Kashanian S; Sweet K; Wang ES; Caddell R; Shafer DA; Singh ZN; Baer MR; Al-Kali A
    Ann Hematol; 2020 Sep; 99(9):2119-2124. PubMed ID: 32676733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed-phenotype acute leukemia characteristics: first report from Iran.
    Poopak B; Khosravi A; Bahoush-Mehdiabadi G; Madani T; Khodadi E; Farahani Z; Vahedi AA; Khosravipour G; Poopak P; Poopak AH
    Clin Exp Med; 2018 Nov; 18(4):513-521. PubMed ID: 30019150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improved clinical outcome of acute myeloid leukemia with FLT3-ITD mutation treated with sorafenib].
    Gu B; Chen GH; Shen HJ; Ma X; Fu CC; Han Y; Tang XW; Miao M; Qiu HY; Sun AN; Wu DP
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):293-7. PubMed ID: 27030618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-hematological profile in biphenotypic acute leukemia.
    Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Amare P; Arora B; Banavali SD; Nair CN
    Indian J Cancer; 2009; 46(2):160-8. PubMed ID: 19346652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience.
    Karasek M; Armatys A; Skarupski M; Bołkun Ł; Budziszewska K; Drozd-Sokołowska J; Zarzycka E; Mensah-Glanowska P; Gajewska M; Hałka J; Kopacz A; Prejzer W; Chyrko O; Wróbel T; Wierzbowska A; Sobas M
    Front Oncol; 2024; 14():1395992. PubMed ID: 38835383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful acute lymphoblastic leukemia-type therapy in two children with mixed-phenotype acute leukemia.
    Otsubo K; Yabe M; Yabe H; Fukumura A; Morimoto T; Kato M; Mochizuki H
    Pediatr Int; 2016 Oct; 58(10):1072-1076. PubMed ID: 27577674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival outcome of childhood acute myeloid leukemia with intensified chemotherapy in Chinese children.
    Zhai XW; Cheng FW; Lee V; Leung WK; Ng MH; Tsang KS; Shing MK; Li CK
    Pediatr Hematol Oncol; 2011 May; 28(4):269-78. PubMed ID: 21345081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.